LYSOCIL: Excel in Rare Diseases’ Research: Focus on LYSOsomal Disorders and CILiopathiesis a H2020 Twinning Project led by NOVA Medical School (NMS) that aims to strengthen the research and innovation capacity of the Chronic Diseases Research Center (CEDOC-NMS|FCM), helping it to become a national and internationally-recognized Centre of Excellence in Chronic rare diseases research and innovation.
LYSOCIL LIG session dedicated to “Alzheimer’s mutation in CD2AP increases intracellular beta-amyloid by reducing APP endosomal sorting”
LYSOCIL LIG session dedicated to “Uncoupling heart and liver laterality events during embryogenesis”
LIG session dedicated to “Lysosome turnover in the retinal pigment epithelium in health, ageing and age-related macular degeneration”
LYSOCIL Coordinator is the new member of the Scientific Council of the Sanfilippo Association in Portugal
Virtual Think Tank (VTT) session dedicated to “The scientific review on the state-of-the-art of the lysosome, cilia and autophagy connection”
Virtual Think Tank (VTT) session dedicated to “Gene Editing as rare disease therapy – main challenges and alternatives”
Second LIG session dedicated to 'Modelling retinal degenerative diseases using 3D retinal organoids'